A Phase III Randomized Trial Comparing Adjuvant versus Early Salvage Radiotherapy, Both Combined with Short-term Androgen Deprivation Therapy, following a Radical Prostatectomy: Initial Results of the GETUG-AFU 17 Study [NCT00667069]

Adjuvant radiotherapy (aRT) may reduce the risk of biochemical failure in patients with pathological high-risk prostate cancer (PCa) following radical prostatectomy (RP). Nevertheless, not all the patients benefit from this approach and the optimal timing of radiotherapy (RT) after RP remains debatable. The GETUG-AFU 17 study, compared aRT versus salvage RT (sRT), combined with short-term androgen deprivation therapy (STADT), in terms of...